Totally agree CJ.
I have sold enough (at what I consider a substantially over the top price as things stand) to completely wipe out my previous overall capital losses, which had accumulate over the past years - thus no tax yet. Sold because I am never going to get into that situation again. Thanks ADO.
[That is why I never ramp a stock. I have been there, and seen that - peoples certain expectation of sudden or future wealth crushed by an unexpected trial result or gradual erosion of paper gains.]
But once tax kicks in, it is a different game. You can't necessarily sell when you think a stock is overpriced with the tactic of buying back in as the SP drops (if assumptions are correct).
IMO, this is the current ADO situation - totally overpriced atm, but this may only be a short to medium term situation. For me, the longer term risk/reward prospect is still very positive from the current SP.
Thus I will not be selling any more. I will confidently ride out (my current) expected SP drop.
[Also, if it don't drop, it don't matter.]
- Forums
- ASX - By Stock
- ADO
- Ann: Quarterly Activities Report
Ann: Quarterly Activities Report, page-83
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
-0.005(18.5%) |
Mkt cap ! $54.77M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $123.2K | 5.805M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 2828323 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 662272 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 2828323 | 0.021 |
20 | 3358245 | 0.020 |
8 | 3328823 | 0.019 |
14 | 3352391 | 0.018 |
5 | 2369748 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 662272 | 3 |
0.023 | 625000 | 3 |
0.024 | 200000 | 1 |
0.025 | 40000 | 1 |
0.026 | 76000 | 2 |
Last trade - 12.58pm 13/11/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online